As filed with the Securities and Exchange Commission on January 26, 2021
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
____________________
TRANSENTERIX, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
Delaware |
11-2962080 |
|
(State or Other Jurisdiction of |
(I.R.S. Employer |
|
Incorporation or Organization) |
Identification Number) |
635 Davis Drive, Suite 300
Morrisville, NC 27560
(919) 765-8400
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal
Executive Offices)
____________________
Shameze Rampertab
EVP and Chief Financial Officer
635 Davis Drive, Suite 300
Morrisville, NC 27560
(919) 765-8400
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)
____________________
With a copy to:
Mary J. Mullany, Esquire
Ballard Spahr LLP
1735 Market Street, 51st Floor
Philadelphia, PA 19103
(215) 864-8631
____________________
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.
If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☐
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ 333-236200
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a registration statement filed pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If this form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):
|
Large Accelerated Filer |
☐ |
Accelerated Filer |
☒ |
|
Non-Accelerated Filer |
☐ |
Smaller Reporting Company |
☒ |
|
Emerging Growth Company |
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for comply with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐
____________________
CALCULATION OF REGISTRATION FEE
|
Title of Securities to be Registered |
Proposed Maximum Aggregate Offering Price (1)(2) |
Amount of Registration Fee (2) |
|
Common Stock, par value $0.001 per share |
||
|
TOTAL |
$13,250,742 |
$1,446 |
|
(1) |
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
|
(2) |
Calculated pursuant to Rule 457(o) based on an estimate of the proposed maximum aggregate offering price. TransEnterix, Inc. previously registered an aggregate principal amount of $150,000,000 of the Company’s securities on the Registration Statement on Form S-3 (Registration No. 333-236200), as amended (the “Related Registration Statement”) and paid a fee of $19,470. In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a proposed maximum aggregate offering price of no more than 20% of the maximum aggregate offering price of the remaining securities eligible to be sold under the Related Registration Statement is hereby registered. |
This registration statement shall become effective upon filing with the Commission in accordance with Rule 462(b) of the Securities Act of 1933, as amended.
EXPLANATORY NOTE AND INCORPORATION BY REFERENCE
TransEnterix, Inc. (the “Company”) is filing this registration statement with the Securities and Exchange Commission, or SEC, pursuant to Rule 462(b) under the Securities Act of 1933, as amended. This registration statement relates to the public offering of securities contemplated by the registration statement on Form S-3 (File No. 333-236200), which was originally filed with the SEC on January 31, 2020 and declared effective on February 10, 2020 (the “Prior Registration Statement”).
The Company is filing this registration statement for the purpose registering additional securities of the Company with an aggregate offering price not to exceed $13,250,742. The information set forth in the Prior Registration Statement, including all exhibits thereto and all information incorporated by reference therein, is incorporated by reference in this filing.
The required opinions and consents are listed on the exhibit index and filed with this filing.
EXHIBIT INDEX
|
Exhibit Number |
Description |
|
|
5.1 |
||
|
23.1 |
||
|
23.2 |
||
|
24.1 |
Power of Attorney (incorporated by reference to Exhibit 24.1 to the Prior Registration Statement) |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Morrisville, State of North Carolina on the 26th day of January, 2021.
|
|
TransEnterix, Inc. |
|
|
|
|
|
|
|
By: |
/s/ Anthony Fernando |
|
|
|
Anthony Fernando |
|
|
|
President and Chief Executive Officer |
| (principal executive officer) | ||
| By: | /s/ Shameze Rampertab | |
| Shameze Rampertab | ||
| Executive Vice President and Chief | ||
| Financial Officer | ||
| (principal financial officer and | ||
| principal accounting officer) | ||
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
|
Signature
|
Title
|
Date
|
|
|
/s/ Anthony Fernando |
President, Chief Executive Officer and Director (principal executive officer) |
January 26, 2021 |
|
|
Anthony Fernando |
|||
|
/s/ Shameze Rampertab |
Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) |
January 26, 2021 |
|
|
Shameze Rampertab |
|||
|
* |
Chairman of the Board and a Director |
January 26, 2021 |
|
|
Paul A. LaViolette |
|||
|
* |
Director |
January 26, 2021 |
|
|
Andrea Biffi |
|||
|
* |
Director |
January 26, 2021 |
|
|
Jane H. Hsiao, Ph.D. |
|||
|
* |
Director |
January 26, 2021 |
|
|
David B. Milne |
|||
|
* |
Director |
January 26, 2021 |
|
|
Richard C. Pfenniger, Jr. |
|||
|
* |
Director |
January 26, 2021 |
|
|
William N. Starling, Jr. |
*By: /s/ Anthony Fernando
Anthony Fernando
Attorney-in-fact
EXHIBIT INDEX
|
Exhibit |
|
Description |
||
|
5.1 |
Opinion of Ballard Spahr LLP. |
|||
|
23.1 |
Consent of BDO USA, LLP. |
|||
|
23.2 |
Consent of Ballard Spahr LLP (included in Exhibit 5.1). |
|||
|
24.1 |
* |
Power of Attorney. |
_____________
* Previously filed with TransEnterix, Inc.’s Registration Statement on Form S-3 (File No. 333-236200) originally filed on January 31, 2020.
 |
Exhibit 5.1 |
January 26, 2021
|
TransEnterix, Inc. 635 Davis Drive, Suite 300 Morrisville, NC 27560
|
|
Re: |
TransEnterix, Inc. |
Ladies and Gentlemen:
We have acted as counsel to TransEnterix, Inc., a Delaware corporation (the “Company”), and are rendering this opinion in connection with the filing of a registration statement under Rule 462 of the Securities Act of 1933, as amended (the “Securities Act”) (the “Rule 462 Registration Statement”), related to a registration statement on Form S-3 (File No. 333-236200) filed by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act, on January 31, 2020 and declared effective on February 10, 2020 (the “Related Registration Statement”). The Rule 462 Registration Statement is being filed by the Company with the Commission, under the Securities Act, for the registration of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), with a proposed maximum aggregate offering price of $13,250,742.
Under the Rule 462 Registration Statement and in connection with the filing of a prospectus supplement (the “Prospectus Supplement”), the Company will offer and sell up to 4,416,914 shares of Common Stock (the “Shares”). The Shares are to be sold by the Company pursuant to an Amended and Restated Underwriting Agreement (the “Agreement”) entered into by and between the Company and H.C. Wainwright & Co., LLC.
We have examined originals or copies, certified or otherwise identified to our satisfaction, of (i) the Rule 462 Registration Statement, (ii) the Related Registration Statement and all exhibits thereto, (iii) the Prospectus Supplement, (iv) the Agreement, (v) the Amended and Restated Certificate of Incorporation of the Company together with all amendments thereto, (vi) the Amended and Restated Bylaws of the Company and (vii) certain resolutions of the Board of Directors of the Company and the Transaction Committee of the Board of Directors of the Company. We have also examined such corporate records and other agreements, documents and instruments, and such certificates or comparable documents of public officials and officers and representatives of the Company, and have made such inquiries of such officers and representatives and have considered such matters of law as we have deemed appropriate as the basis for the opinions hereinafter set forth.
Atlanta | Baltimore | Bethesda | Delaware | Denver | Las Vegas | Los Angeles | New Jersey | New York | Philadelphia | Phoenix
Salt Lake City | San Diego | Washington, DC | www.ballardspahr.com
TransEnterix, Inc.
January 26, 2021
Page 2
In delivering this opinion, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as certified, photostatic or conformed copies, the authenticity of originals of all such latter documents, and the accuracy and completeness of all records, information and statements submitted to us by officers and representatives of the Company. In making our examination of documents executed by parties other than the Company, we have assumed that such parties had the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization of all requisite action, corporate or other, and execution and delivery by such parties of such documents and the validity and binding effect thereof with respect to such parties.
Based upon and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that, with respect to the offering of the Shares by the Company pursuant to the Rule 462 Registration Statement, when the Rule 462 Registration Statement has become effective under the Securities Act, the Shares to be issued and sold by the Company have been duly authorized for issuance and, when issued and paid for in accordance with the terms and conditions of the Agreement, will be validly issued, fully paid and non-assessable.
The opinions expressed herein are subject to the effect of applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, fraudulent transfer, marshalling or similar laws affecting creditors’ rights and remedies generally; general principles of equity, including without limitation, concepts of materiality, reasonableness, good faith and fair dealing (regardless of whether such enforceability is considered in a proceeding in equity or at law); and limitations on enforceability of rights to indemnification or contribution by federal or state securities laws or regulations or by public policy.
We express no opinion as to the laws of any jurisdiction other than the present federal laws of the United States of America, the present laws of the State of Delaware and the present laws of the State of New York.
We hereby consent to the sole use of this opinion as an exhibit to the Rule 462 Registration Statement and to the use of our name under the heading “Legal Matters” in the prospectus included therein. In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the Securities Act and the rules and regulations promulgated thereunder.
Very truly yours,
/s/ Ballard Spahr LLP
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
TransEnterix, Inc.
Morrisville, North Carolina
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, of our reports dated March 16, 2020, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting of TransEnterix, Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, which are incorporated by reference in the Registration Statement on Form S-3 (File No. 333-236200). Our report on the consolidated financial statements contains an explanatory paragraph regarding the Company’s ability to continue as a going concern. Our report on the effectiveness of internal control over financial reporting expresses an adverse opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2019.
We also consent to the reference to us under the caption “Experts” in the Registration Statement on Form S-3 (File No. 333-236200).
/s/BDO USA, LLP
Raleigh, North Carolina
January 26, 2021